Status:

COMPLETED

Advanced XLIF Monitoring Multicenter Study

Lead Sponsor:

NuVasive

Conditions:

Degenerative Lumbar Disc Disease

Eligibility:

All Genders

18-80 years

Brief Summary

The objective of this study is to evaluate the utility of localized stimulation of the lumbosacral nerve roots during XLIF through correlation of observed changes in the response latency, amplitude, w...

Detailed Description

The utility of NVM5 neuromonitoring by stimulating within the surgical site during XLIF has been previously demonstrated; however, it is possible that depending on the site of injury, this method of m...

Eligibility Criteria

Inclusion

  • Male and female spine surgery patients who are at least 18 years of age;
  • Persistent back and/or leg pain unresponsive to conservative treatment for at least six (6) months, unless surgical treatment is clinically indicated earlier;
  • Surgical candidates for extreme lateral approach lumbar spine surgery at spinal levels L2 to L5, inclusive of L4-5;
  • Able to undergo surgery based on physical exam, medical history and surgeon judgment;
  • Patients who understand the conditions of enrollment and are willing to sign an informed consent to participate in the evaluation.

Exclusion

  • Patient has a mental or physical condition that would limit the ability to comply with study requirements;
  • Currently undergoing any surgical treatment at any spinal level other than L2 to L5;
  • Currently undergoing surgical treatment for significant deformity correction (e.g., osteotomy, anterior longitudinal ligament release, or other significant manipulation of the spinal column);
  • Underlying neurological disease or neurological deficit that is not associated with the condition for which he/she is seeking surgical intervention (e.g., diabetic peripheral neuropathy);
  • Implanted pacemaker, defibrillator, or other electronic devices;
  • Involved in active litigation relating to the spine (worker's compensation claim is allowed if it is not contested);
  • Pregnant women;
  • Patient is a prisoner;
  • Patient is participating in another clinical study that would confound study data.

Key Trial Info

Start Date :

July 9 2014

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

October 1 2017

Estimated Enrollment :

324 Patients enrolled

Trial Details

Trial ID

NCT02272140

Start Date

July 9 2014

End Date

October 1 2017

Last Update

December 22 2025

Active Locations (12)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (12 locations)

1

Scripps Clinical Research Services

La Jolla, California, United States, 92037

2

USF Neurology and Neurosurgery

Tampa, Florida, United States, 33606

3

Foundation for Orthopaedic Research and Education (FORE)

Tampa, Florida, United States, 33637

4

Piedmont Healthcare

Atlanta, Georgia, United States, 30309